Kristine Misund

Forsker
ved Institutt for klinisk og molekylær medisin ved Norges teknisk-naturvitenskapelige universitet

Resultater Resultater

Progression of monoclonal gammopathy of undetermined significance to multiple myeloma is associated with enhanced translational quality control and overall loss of surface antigens.

Berg, Sigrid Ravn; Demirovic, Aida; Sharma, Animesh; Hagen, Lars; Vågbø, Cathrine Broberg; Zatula, Alexey; Misund, Kristine; Waage, Anders; Slupphaug, Geir. 2024, Journal of Translational Medicine. STOLAV, NTNUVitenskapelig artikkel

Genome-Wide CRISPR/Cas9 Knock-out Screen Identifies Apoptosis-Relevant Genes in Multiple Myeloma.

Andersson-Rusch, Clara Leticia; Quist-Løkken, Ingrid; Sætrom, Pål; Beisvag, Vidar; Rolinski, Milosz; Møen, Johanna; Misund, Kristine; Aas, Per Arne; van Loon, Barbara; Holien, Toril. 2023, 65th ASH Annual Meeting and Exposition. STOLAV, NTNUPoster

A patient with minimal myeloma treatment who survived for 20 years.

Behsen, Alenka Djarmila; Vandsemb, Esten Nymoen; Slørdahl, Tobias Schmidt; Hjorth-Hansen, Henrik; Quist-Paulsen, Petter; Misund, Kristine; Sponaas, Anne Marit; Waage, Anders. 2023, Haematologica. STOLAV, NTNU, BIOVitenskapelig artikkel

IL-32 is induced by activation of toll-like receptors in multiple myeloma cells.

Aass, Kristin Roseth; Tryggestad, Synne Stokke; Mjelle, Robin; Kastnes, Martin Haugrud; Nedal, Tonje Marie Vikene; Misund, Kristine; Standal, Therese. 2023, Frontiers in Immunology. STOLAV, NTNUVitenskapelig artikkel

Altered composition of CD8 T cell subsets over time in the bone marrow of multiple myeloma patients with long- and short-term disease control.

Behsen, Alenka Djarmila; Vandsemb, Esten Nymoen; Waage, Anders; Slørdahl, Tobias Schmidt; Sponaas, Anne Marit; Misund, Kristine. 2022, International Myeloma Society Annual Meeting. STOLAV, NTNUVitenskapelig foredrag

1 - 5 av 126 | Neste | Siste »